Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) was the target of some unusual options trading on Monday. Stock traders acquired 5,030 call options on the stock. This is an increase of 392% compared to the average volume of 1,023 call options.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on ALHC shares. UBS Group raised their price target on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Robert W. Baird raised their target price on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Stifel Nicolaus raised their price target on Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Alignment Healthcare has a consensus rating of "Moderate Buy" and an average target price of $17.17.
View Our Latest Stock Report on Alignment Healthcare
Insiders Place Their Bets
In other Alignment Healthcare news, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of Alignment Healthcare stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $15.28, for a total transaction of $259,760,000.00. Following the completion of the sale, the director directly owned 44,302,175 shares in the company, valued at $676,937,234. The trade was a 27.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Andreas P. Wagner sold 19,399 shares of the firm's stock in a transaction that occurred on Wednesday, June 11th. The stock was sold at an average price of $15.26, for a total value of $296,028.74. Following the transaction, the insider owned 204,075 shares in the company, valued at approximately $3,114,184.50. The trade was a 8.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 17,795,262 shares of company stock valued at $272,980,496 over the last ninety days. 7.00% of the stock is owned by insiders.
Institutional Trading of Alignment Healthcare
A number of large investors have recently made changes to their positions in ALHC. Amalgamated Bank raised its holdings in Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after purchasing an additional 616 shares in the last quarter. Ballentine Partners LLC increased its position in Alignment Healthcare by 8.6% during the 1st quarter. Ballentine Partners LLC now owns 11,674 shares of the company's stock worth $217,000 after purchasing an additional 924 shares in the last quarter. MCF Advisors LLC boosted its position in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the period. Cresset Asset Management LLC raised its holdings in shares of Alignment Healthcare by 0.6% during the 1st quarter. Cresset Asset Management LLC now owns 287,565 shares of the company's stock valued at $5,354,000 after buying an additional 1,797 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Alignment Healthcare by 3.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,963 shares of the company's stock worth $641,000 after purchasing an additional 2,154 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.
Alignment Healthcare Price Performance
ALHC stock traded down $0.52 during trading on Thursday, hitting $13.38. The stock had a trading volume of 2,611,439 shares, compared to its average volume of 2,226,025. The stock has a market capitalization of $2.65 billion, a P/E ratio of -27.88 and a beta of 1.16. Alignment Healthcare has a twelve month low of $7.92 and a twelve month high of $21.06. The company's 50-day moving average price is $14.77 and its two-hundred day moving average price is $15.19. The company has a debt-to-equity ratio of 2.95, a current ratio of 1.69 and a quick ratio of 1.69.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.07. The business had revenue of $926.93 million for the quarter, compared to analysts' expectations of $889.83 million. Alignment Healthcare had a negative net margin of 3.02% and a negative return on equity of 80.49%. The business's quarterly revenue was up 47.5% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.25) earnings per share. As a group, research analysts predict that Alignment Healthcare will post -0.69 EPS for the current fiscal year.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Stories
Before you consider Alignment Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.
While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.